In 1990 Dr. Pandey joined the Photodynamic Therapy (PDT) Center at Roswell Park Cancer Institute where he is currently associated as Distinguished Professor and Director of Pharmaceutical Chemistry, Dept. of Cell Stress Biology. He also has an appointment as Professor with the Institute of Lasers, Photonics and Biophotonics, SUNY at Buffalo. Recent research has been focused on developing compounds for tumor imaging and/or PDT.

Mr. Friedman is a co-founder and board member of Photolitec, LLC, as well as a Managing Partner at Lippes Mathias Wexler Frideman LLP. As a partner in the firm's business and financial transactions group, Mr. Friedman concentrates his practice on general business matters, with particular emphasis on venture capital financing transactions and on representing family-owned and closely-held businesses as well as professional partnerships.

Dr. Dugar is President and CEO of Sphaera Pharma and serves as Chief Advisor for Photolitec. He has extensive experience in the pharmaceutical industry with a deep understanding of the drug discovery and development process. He is also well acquainted with the US IND submission process and clinical development (Phase I, Phase II and Phase III clinical trials).